Harnessing viral devices as pharmaceuticals: Fighting HIV-1's fire with fire

Article Abstract:

Most modern biomedical endeavors aimed to combat disease processes through an understanding of the way in which a dynamic system operates. The challenge is to target the drug selectively, and the philosophy of 'selective toxicity' is applied to reports of anti-HIV-1 strategies using sophisticatedly engineered viruses able to seek and kill human cells displaying markets of HIV-1 infection. The therapeutic possibilities are further discussed.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Thinking big about global health

Article Abstract:

The Gates Foundation is funding high-risk research into new ways to improve health in developing countries. The Foundation has dedicated $1.1 billion to fighting AIDS/HIV, $640 million into combating malaria, and $900 million to tuberculosis while it has poured another 1.5 billion into the Global Alliance for vaccines to roughly 130 million youngsters thus saving an estimated 1.7 million lives in more than 70 countries.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

The development and impact of tuberculosis vaccines

Article Abstract:

The strategies to combat tuberculosis (TB) were announced in the worldwide economic forum in Davos, Switzerland in January 2006, which are set out in The Global Plan to Stop TB. This plan addresses the UN Millennium Development Goal of halving the TB prevalence and death rates by the year 2015 and vaccination is expected to make a major contribution to the goal of eliminating TB worldwide.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: